Evogene Ltd. (TLV:EVGN)
385.10
-14.80 (-3.70%)
Nov 6, 2025, 5:24 PM IDT
Evogene Revenue
Evogene had revenue of $884.00K USD in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $9.44M, up 42.25% year-over-year. In the year 2024, Evogene had annual revenue of $8.51M with 50.90% growth.
Revenue (ttm)
$9.44M
Revenue Growth
+42.25%
P/S Ratio
1.07
Revenue / Employee
$80.72K
Employees
117
Market Cap
34.01M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.51M | 2.87M | 50.90% |
| Dec 31, 2023 | 5.64M | 3.97M | 236.72% |
| Dec 31, 2022 | 1.68M | 745.00K | 80.11% |
| Dec 31, 2021 | 930.00K | -110.00K | -10.58% |
| Dec 31, 2020 | 1.04M | 287.00K | 38.11% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.84B |
| Novolog (Pharm-Up 1966) | 2.04B |
| Ilex Medical | 927.57M |
| Kamada | 571.15M |
| SofWave Medical | 255.13M |
| InterCure | 243.12M |
| BrainsWay | 155.27M |
Evogene News
- 3 days ago - Evogene Schedules Third Quarter 2025 Financial Results Release - PRNewsWire
- 2 months ago - Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York - PRNewsWire
- 2 months ago - Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Evogene GAAP EPS of -$0.85 misses by $0.22, revenue of $0.88M misses by $0.05M - Seeking Alpha
- 2 months ago - Evogene Reports Second Quarter 2025 Financial Results - PRNewsWire
- 2 months ago - Evogene Q2 2025 Earnings Preview - Seeking Alpha
- 2 months ago - Preview: Evogene's Earnings - Benzinga
- 3 months ago - Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases - PRNewsWire